Hepatic stellate cell promoted hepatoma cell invasion via the HGF/c-Met signaling pathway regulated by p53

References

• Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127:S5-S16; PMID:15508102; http://dx.doi.org/10.1053/j.gastro.2004.09.011
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: a Cancer Journal for Clinicians 2011; 61:69-90; PMID:21296855
   PubMed Web of Science ®Google Scholar
• Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006; 6:674-87; PMID:16929323; http://dx.doi.org/10.1038/nrc1934
   PubMed Web of Science ®Google Scholar
• Llovet JM, Bruix J. Molecular targeted therapies in hepatocellular carcinoma. Hepatology 2008; 48:1312-27; PMID:18821591; http://dx.doi.org/10.1002/hep.22506
   PubMed Web of Science ®Google Scholar
• Thompson AI, Conroy KP, Henderson NC. Hepatic stellate cells: central modulators of hepatic carcinogenesis. BMC Gastroenterol 2015; 15:63; PMID:26013123; http://dx.doi.org/10.1186/s12876-015-0291-5
   PubMed Web of Science ®Google Scholar
• Carloni V, Luong TV, Rombouts K. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever. Liver Int 2014; 34:834-43; PMID:24397349; http://dx.doi.org/10.1111/liv.12465
   PubMed Web of Science ®Google Scholar
• Amann T, Bataille F, Spruss T, Muhlbauer M, Gabele E, Scholmerich J, Kiefer P, Bosserhoff AK, Hellerbrand C. Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Sci 2009; 100:646-53; PMID:19175606; http://dx.doi.org/10.1111/j.1349-7006.2009.01087.x
   PubMed Web of Science ®Google Scholar
• Yu G, Jing Y, Kou X, Ye F, Gao L, Fan Q, Yang Y, Zhao Q, Li R, Wu M, et al. Hepatic stellate cells secreted hepatocyte growth factor contributes to the chemoresistance of hepatocellular carcinoma. PloS one 2013; 8:e73312; PMID:24023859; http://dx.doi.org/10.1371/journal.pone.0073312
   PubMed Web of Science ®Google Scholar
• Jeffers M, Fiscella M, Webb CP, Anver M, Koochekpour S, Vande Woude GF. The mutationally activated Met receptor mediates motility and metastasis. Proc Natl Acad Sci U S A 1998; 95:14417-22; PMID:9826715; http://dx.doi.org/10.1073/pnas.95.24.14417
   PubMed Web of Science ®Google Scholar
• Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991; 67:901-8; PMID:1835669; http://dx.doi.org/10.1016/0092-8674(91)90363-4
   PubMed Web of Science ®Google Scholar
• Zarnegar R, Michalopoulos GK. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 1995; 129:1177-80; PMID:7775566; http://dx.doi.org/10.1083/jcb.129.5.1177
   PubMed Web of Science ®Google Scholar
• Kolatsi-Joannou M, Moore R, Winyard PJ, Woolf AS. Expression of hepatocyte growth factor/scatter factor and its receptor, MET, suggests roles in human embryonic organogenesis. Pediatric Res 1997; 41:657-65; PMID:9128288; http://dx.doi.org/10.1203/00006450-199705000-00010
   PubMed Web of Science ®Google Scholar
• Wang Y, Selden C, Farnaud S, Calnan D, Hodgson HJ. Hepatocyte growth factor (HGF/SF) is expressed in human epithelial cells during embryonic development; studies by in situ hybridisation and northern blot analysis. J Anatomy 1994; 185(Pt 3):543-51; PMID:7649790
   PubMed Web of Science ®Google Scholar
• Cao HH, Cheng CY, Su T, Fu XQ, Guo H, Li T, Tse AK, Kwan HY, Yu H, Yu ZL. Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion. Mol Cancer 2015; 14:103; PMID:25971889; http://dx.doi.org/10.1186/s12943-015-0367-4
   PubMed Web of Science ®Google Scholar
• Hwang CI, Matoso A, Corney DC, Flesken-Nikitin A, Korner S, Wang W, Boccaccio C, Thorgeirsson SS, Comoglio PM, Hermeking H, et al. Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. Proc Natl Acad Sci U S A 2011; 108:14240-5; PMID:21831840; http://dx.doi.org/10.1073/pnas.1017536108
   PubMed Web of Science ®Google Scholar
• Tepper CG, Gregg JP, Shi XB, Vinall RL, Baron CA, Ryan PE, Desprez PY, Kung HJ, deVere White RW. Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells. Prostate 2005; 65:375-89; PMID:16037992; http://dx.doi.org/10.1002/pros.20308
   PubMed Web of Science ®Google Scholar
• Di Agostino S, Strano S, Emiliozzi V, Zerbini V, Mottolese M, Sacchi A, Blandino G, Piaggio G. Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation. Cancer Cell 2006; 10:191-202; PMID:16959611; http://dx.doi.org/10.1016/j.ccr.2006.08.013
   PubMed Web of Science ®Google Scholar
• O'Farrell TJ, Ghosh P, Dobashi N, Sasaki CY, Longo DL. Comparison of the effect of mutant and wild-type p53 on global gene expression. Cancer Res 2004; 64:8199-207; PMID:15548685; http://dx.doi.org/10.1158/0008-5472.CAN-03-3639
   PubMed Web of Science ®Google Scholar
• de Herreros AG, Peiro S, Nassour M, Savagner P. Snail family regulation and epithelial mesenchymal transitions in breast cancer progression. J Mammary Gland Biol Neoplasia 2010; 15:135-47; PMID:20455012; http://dx.doi.org/10.1007/s10911-010-9179-8
   PubMed Web of Science ®Google Scholar
• Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003; 4:915-25; PMID:14685170; http://dx.doi.org/10.1038/nrm1261
   PubMed Web of Science ®Google Scholar
• Stoker M, Perryman M. An epithelial scatter factor released by embryo fibroblasts. J of Cell Sci 1985; 77:209-23; PMID:3841349
   PubMed Web of Science ®Google Scholar
• Tavian D, De Petro G, Benetti A, Portolani N, Giulini SM, Barlati S. u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma. Int J Cancer J Int du Cancer 2000; 87:644-9; PMID:10925356; http://dx.doi.org/10.1002/1097-0215(20000901)87:5%3c644::AID-IJC4%3e3.0.CO;2-W
   PubMed Web of Science ®Google Scholar
• Comoglio PM, Giordano S, Trusolino L. Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Dis 2008; 7:504-16; PMID:18511928; http://dx.doi.org/10.1038/nrd2530
   PubMed Web of Science ®Google Scholar
• Seol DW, Chen Q, Smith ML, Zarnegar R. Regulation of the c-met proto-oncogene promoter by p53. J Biol Chem 1999; 274:3565-72; PMID:9920903; http://dx.doi.org/10.1074/jbc.274.6.3565
   PubMed Web of Science ®Google Scholar
• Hwang CI, Choi J, Zhou Z, Flesken-Nikitin A, Tarakhovsky A, Nikitin AY. MET-dependent cancer invasion may be preprogrammed by early alterations of p53-regulated feedforward loop and triggered by stromal cell-derived HGF. Cell Cycle 2011; 10:3834-40; PMID:22071625; http://dx.doi.org/10.4161/cc.10.22.18294
   PubMed Web of Science ®Google Scholar
• Hsu HC, Peng SY, Lai PL, Sheu JC, Chen DS, Lin LI, Slagle BL, Butel JS. Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients. Cancer 1994; 73:42-7; PMID:7506118; http://dx.doi.org/10.1002/1097-0142(19940101)73:1%3c42::AID-CNCR2820730109%3e3.0.CO;2-D
   PubMed Web of Science ®Google Scholar
• Hsu HC, Tseng HJ, Lai PL, Lee PH, Peng SY. Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness. Cancer Res 1993; 53:4691-4; PMID:8402647
   PubMed Web of Science ®Google Scholar
• Liu SH, Lin CY, Peng SY, Jeng YM, Pan HW, Lai PL, Liu CL, Hsu HC. Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation. Am J Pathol 2002; 160:1831-7; PMID:12000734; http://dx.doi.org/10.1016/S0002-9440(10)61129-7
   PubMed Web of Science ®Google Scholar
• Chu JS, Ge FJ, Zhang B, Wang Y, Silvestris N, Liu LJ, Zhao CH, Lin L, Brunetti AE, Fu YL, et al. Expression and prognostic value of VEGFR-2, PDGFR-beta, and c-Met in advanced hepatocellular carcinoma. J Exp Clin Cancer Res 2013; 32:16; PMID:NOT_FOUND; http://dx.doi.org/10.1186/1756-9966-32-16
   PubMedGoogle Scholar
• Tan C, Costello P, Sanghera J, Dominguez D, Baulida J, de Herreros AG, Dedhar S. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC−/− human colon carcinoma cells. Oncogene 2001; 20:133-40; PMID:11244511; http://dx.doi.org/10.1038/sj.onc.1204052
   PubMed Web of Science ®Google Scholar
• Gotzmann J, Huber H, Thallinger C, Wolschek M, Jansen B, Schulte-Hermann R, Beug H, Mikulits W. Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps towards invasiveness. J Cell Sci 2002; 115:1189-202; PMID:11884518
   PubMed Web of Science ®Google Scholar
• Grotegut S, von Schweinitz D, Christofori G, Lehembre F. Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J 2006; 25:3534-45; PMID:16858414; http://dx.doi.org/10.1038/sj.emboj.7601213
   PubMed Web of Science ®Google Scholar
• Sugimachi K, Tanaka S, Kameyama T, Taguchi K, Aishima S, Shimada M, Sugimachi K, Tsuneyoshi M. Transcriptional repressor snail and progression of human hepatocellular carcinoma. Clin Cancer Res 2003; 9:2657-64; PMID:12855644
   PubMed Web of Science ®Google Scholar